AIDX
20/20 Biolabs, Inc. Common Stock
NASDAQ: AIDX · HEALTHCARE · MEDICAL DEVICES
$1.49
-1.97% today
Updated 2026-05-05
Market cap
$15.62M
P/E ratio
—
P/S ratio
7.64x
EPS (TTM)
$-0.36
Dividend yield
—
52W range
$1 – $50
Volume
0.2M
20/20 Biolabs, Inc. Common Stock (AIDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.89M | $-1.06M | $-1.31M | $-2.12M | $-2.04M | $-1.07M | $5.80M | $-4.63M | $-2.60M | $-1.92B |
| Capital expenditures | $0.00 | $5.00 | $64076.00 | $2292.00 | $184072.00 | $228147.00 | $261789.00 | $9382.00 | $5.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | $1.30M | $2.18M | $516180.00 |
| Free cash flow | $-1.89M | $-1.06M | $-1.38M | $-2.13M | $-2.22M | $-1.30M | $5.54M | $-4.64M | $-2.60M | $-1.92B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |